Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 24 (RPL17P24)

Target
RPL17P24
Molecular classification
Other (Processed pseudogene)
01

Overview

RPL17P24 (ribosomal protein L17 pseudogene 24) is a processed pseudogene derived from the parental ribosomal protein L17 gene (RPL17). Pseudogenes are typically the result of gene duplication or retrotransposition events and, unlike their coding counterparts, do not encode a functional protein. The RPL17 gene codes for a component of the large 60S ribosomal subunit, but RPL17P24 itself does not produce a functional protein and is generally considered biologically inactive with respect to translation or ribosomal function. Pseudogenes like RPL17P24 are abundant throughout the genome and rarely exhibit direct involvement in disease or therapeutic processes. While the functional RPL17 is beyond the scope of this specific entry, it is important to note that RPL17P24 should not be referred to or utilized as a drug or biomarker target in biomedical research.

Other names
RPL17_16_771RPL17P24
02

Mechanism of action

not a drug target

03

Biological functions

Other (No known direct biological function, as pseudogenes are generally non-functional copies of genes)
04

Disease associations

Other (No established role in disease; not implicated as a causative factor)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 24 (RPL17P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 24 (RPL17P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call